Scribe Therapeutics

Pencil eraser erasing drawn human figure

Biotech

Gene editor Scribe slims down workforce as it readies for clinic

The Bay Area biotech is laying off around 20% of its employees as it shifts its focus toward clinical development.

Darren Incorvaia Jan 8, 2025 5:33pm

DNA gene therapy gene editing helix CRISPR

Sanofi, Scribe seal new in vivo collab worth more than $1.2B

Jul 17, 2023 11:30am

scribe papyrus papers feather pen jot write archive

Scribe's CRISPR tech Prevails with new $1.5B Lilly biobucks deal

May 16, 2023 9:00am

Sanofi

Sanofi pays Scribe $25M for CRISPR NK cell therapy project

Sep 27, 2022 8:15am

chutes and ladders chutes

J&J's Mammen abruptly leaves top R&D job—Chutes & Ladders

Aug 12, 2022 9:30am

Gene editing gene therapy CRISPR

Biogen takes another dip into Scribe gene therapy collab

May 2, 2022 3:03pm